"E" to "Bath Salts": Synthetic Psychostimulants and Hallucinogens | Silas Smith, MD
This lecture covers the presentation, epidemiology, and pharmacology, of synthetic psychostimulants and hallucinogens
PRICE/PURCHASE -- $50
You must sign in or register register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and click "Add to Cart."
PHYSICIANS: The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 1 AMA/PRA Category 1 Credits™ for completing the Review Course.
Continuing education credit is also available for nurses, psychologists, pharmacists, physician assistants, therapists, and drug abuse counselors.
- Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
- Primary care clinicians who want to get a better understanding of addiction and manage patients with addictions in their practice
- Public health officials who want an understanding of the current state of addiction treatment
- Non-physicians who are involved in the treatment of addiction
At the end of this activity the learner should be more competent in the diagnosis and treatment of abuse and addiction to hallucinogens, club drugs, and new drugs of abuse including the following:
- Recognizing the signs and symptoms of abuse (including acute intoxication), addiction to hallucinogens (including psilocybin, LSD, and mescaline), club drugs (such as MDMA (Ecstacy), and GHB) and new and emerging drugs
- Understanding the epidemiology, both analytic and descriptive of addiction to these substances, with a focus on special populations.
- Understanding the genetics behind the abuse and addiction of these substances, as well as any psycho-social pre-dispositions to this behavior.
- Understanding the neurophysiology specific to these forms of addiction.
- Being aware of and sensitive to specific cultural and linguistic differences in patients presenting with abuse or addiction to these substances.
Silas Smith, MD
Dr. Silas Smith is an assistant professor at NYU’s Ronald O. Perelman Department of Emergency Medicine and currently serves as chief of its Section on Quality, Safety and Practice Innovation. He is an Affiliate Faculty Member of NYU Langone Medical Center’s Institute for Innovations in Medical Education. He directs the Kenneth and JoAnn G. Wellner fellowship in emergency department safety and quality and is Associate Director for the fellowship in medical toxicology at NYU and the New York City Poison Control Center. He practices emergency medicine and medical toxicology at NYU Langone Medical Center and Bellevue Hospital Center.
Dr. Smith completed emergency medicine residency and medical toxicology fellowship following service as a naval flight surgeon and also completed the American Hospital Association-National Patient Safety Foundation Patient Safety Leadership Fellowship. He has been active in undergraduate and graduate medical education and research in toxicology, pharmacology, emergency medicine, disaster management, quality, and safety since joining NYU’s faculty in 2008.
Dr. Smith has no relevant financial relationships to disclose
- 1.00 AMA Category 1
- 1.00 Attendance